GoodRx Holdings, Inc.
GDRX
$2.81
-$0.02-0.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.40% | 1.23% | 2.57% | 0.99% | 8.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.40% | 1.23% | 2.57% | 0.99% | 8.50% |
| Cost of Revenue | 14.85% | 12.47% | 7.19% | 14.27% | -37.59% |
| Gross Profit | -0.52% | 0.52% | 2.26% | 0.22% | 13.85% |
| SG&A Expenses | 0.05% | -6.44% | -7.04% | -9.91% | -9.02% |
| Depreciation & Amortization | 22.22% | 16.29% | 31.18% | 717.59% | -46.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.75% | -2.47% | -1.31% | 16.06% | -19.90% |
| Operating Income | -28.36% | 34.87% | 36.35% | -34.40% | 153.24% |
| Income Before Tax | -24.80% | 68.10% | 5,588.74% | 146.31% | 117.41% |
| Income Tax Expenses | 20.11% | 35.99% | 331.34% | 278.36% | 151.16% |
| Earnings from Continuing Operations | -71.78% | 91.86% | 1,195.34% | 126.05% | 110.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.78% | 91.86% | 1,195.34% | 126.05% | 110.30% |
| EBIT | -28.36% | 34.87% | 36.35% | -34.40% | 153.24% |
| EBITDA | -4.98% | 26.31% | 34.08% | -33.55% | 815.08% |
| EPS Basic | -69.23% | 102.25% | 1,219.23% | 127.57% | 111.17% |
| Normalized Basic EPS | -34.52% | 77.72% | 62.91% | -35.96% | 125.04% |
| EPS Diluted | -68.00% | 102.25% | 1,219.23% | 127.57% | 110.96% |
| Normalized Diluted EPS | -32.93% | 81.48% | 62.91% | -36.21% | 124.44% |
| Average Basic Shares Outstanding | -8.66% | -5.22% | -2.78% | -5.37% | -8.17% |
| Average Diluted Shares Outstanding | -10.47% | -7.17% | -2.66% | -4.88% | -6.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |